Why Many Oral Opioids Don't Work as Well in Dogs as They Do in People.

By Steve Mehler, DVM, DACVS

For many pet owners—and even some veterinary professionals—that statement comes as a surprise.

After all, medications like morphine, oxycodone, hydrocodone, codeine, and tramadol are among the best-known pain relievers in human medicine. If they're powerful in people, shouldn't they be equally effective in dogs?

Not necessarily.

One of the most important lessons in veterinary pharmacology is that species matter. Dogs are not simply smaller humans. Their digestive systems, liver enzymes, and metabolic pathways differ in ways that can dramatically change how medications behave inside the body.

This is especially true for oral opioids.

Pain Relief Begins with the Opioid Receptor

Opioids relieve pain by binding to opioid receptors in the brain and spinal cord, particularly the mu (μ) opioid receptor.

When activated, these receptors reduce the transmission of pain signals, making painful stimuli less likely to reach conscious perception.

Injectable opioids such as morphine, hydromorphone, fentanyl, and methadone remain some of the most effective analgesics available in veterinary medicine and are indispensable during surgery and hospitalization.

The challenge begins when many of these drugs are administered orally.

Why Route of Administration Matters

Giving a medication by mouth seems simple.

The tablet is swallowed, absorbed through the intestines, enters the bloodstream, and reaches its target.

In reality, several hurdles stand in the way.

An oral medication must:

• Survive the acidic stomach.

• Be absorbed through the intestinal wall.

• Avoid being pumped back into the intestine.

• Pass through the liver before entering systemic circulation.

• Reach adequate blood concentrations to produce an effect.

Every one of these steps can reduce the amount of active drug available.

The percentage of an orally administered drug that ultimately reaches the bloodstream is known as oral bioavailability.

For several opioids, dogs have surprisingly poor oral bioavailability.

First-Pass Metabolism: The Liver's Filter

One of the biggest reasons oral opioids underperform in dogs is first-pass metabolism.

After absorption from the intestine, blood travels directly to the liver before reaching the rest of the body.

The liver is exceptionally efficient at breaking down many drugs.

For some opioids, the liver destroys a large percentage of the medication before it ever reaches circulation.

Injectable drugs bypass much of this first-pass effect, which explains why the same medication may work well by injection but poorly when given orally.

Why Individual Opioids Behave Differently

Morphine

Morphine is one of the gold standards for injectable pain control.

Given intravenously or intramuscularly, it provides excellent analgesia.

Given orally, however, dogs metabolize much of the drug during first-pass metabolism, leaving relatively little active drug available.

The result is inconsistent pain relief compared with injectable administration.

Codeine

Codeine is actually a relatively weak opioid.

Much of its pain-relieving effect depends on being converted into morphine by liver enzymes.

Humans generally perform this conversion efficiently.

Dogs do not.

Because many dogs convert very little codeine into morphine, the medication often produces minimal analgesia.

Tramadol

Perhaps no oral opioid has generated more controversy in veterinary medicine than tramadol.

For years it became one of the most commonly prescribed pain medications for dogs.

Its popularity was understandable:

• It is inexpensive.

• It is not an NSAID.

• It is relatively safe.

• It works well in many human patients.

The problem is that tramadol relies heavily on conversion into an active metabolite called O-desmethyltramadol (M1).

Dogs generally produce much lower concentrations of this metabolite than humans.

As a result, numerous studies have found little evidence that tramadol alone provides meaningful analgesia for many common orthopedic conditions in dogs.

While some dogs may experience mild sedation or behavioral changes, those effects should not be mistaken for adequate pain control.

Hydrocodone

Hydrocodone also undergoes metabolic conversion before reaching full analgesic activity.

Dogs exhibit considerable variability in this process.

Some animals achieve therapeutic concentrations, while others do not.

Clinical responses are therefore less predictable than in people.

Oxycodone

Oxycodone has excellent oral bioavailability in humans.

In dogs, however, absorption and metabolism are considerably more variable.

Although research is ongoing, current evidence suggests that oral oxycodone produces inconsistent plasma concentrations and less predictable clinical analgesia than injectable opioids.

Sedation Is Not the Same as Pain Relief

One of the most common misconceptions in pain management is assuming that a sleepy dog is a comfortable dog.

Sedation and analgesia are very different physiological effects.

A sedated dog may:

• Sleep more.

• Move less.

• Appear quieter.

Yet still experience significant pain.

Modern pain assessment focuses on mobility, posture, appetite, interaction, facial expression, and validated pain scoring systems rather than simply whether a patient appears sleepy.

When Oral Opioids Still Have a Role

This doesn't mean oral opioids should never be used.

They can still be valuable in selected patients, including:

• Cancer pain

• Palliative and hospice care

• Certain chronic pain syndromes

• Patients that cannot tolerate NSAIDs

• Individual cases where multimodal analgesia requires additional support

The important point is that they should not be expected to perform identically to injectable opioids or to human pain medications.

Modern Veterinary Pain Management Is Multimodal

Today's approach to pain management recognizes that no single medication is perfect.

Instead, veterinarians combine therapies that work through different mechanisms.

Depending on the patient, this may include:

• NSAIDs

• Local anesthetic nerve blocks

• Epidurals

• Injectable opioids

• Ketamine

• Gabapentin (for selected indications)

• Amantadine

• Physical rehabilitation

• Weight management

• Environmental modification

By targeting multiple pain pathways simultaneously, lower doses of each medication can often be used while achieving superior pain control.

This approach is known as multimodal analgesia, and it has become the standard of care in modern veterinary medicine.

The Future of Veterinary Pain Control

Pain management continues to evolve rapidly.

Researchers are developing better species-specific medications while improving our understanding of canine pharmacology.

Rather than simply borrowing treatments from human medicine, veterinary researchers are increasingly asking a better question:

How do dogs actually process these medications?

That shift has fundamentally changed how veterinarians think about oral opioids.

The Bottom Line

Strong pain medications in humans are not automatically strong pain medications in dogs.

Species differences in absorption, metabolism, first-pass hepatic breakdown, and drug activation mean that many oral opioids produce far less reliable analgesia in canine patients than many people expect.

Fortunately, veterinary medicine has moved toward evidence-based, multimodal pain management strategies that provide safer and more effective pain relief.

Understanding these pharmacologic differences allows veterinarians to choose treatments based on science—not assumptions—and ultimately improves the comfort and recovery of our patients.

Because the goal isn't simply to make a dog sleepy.

The goal is to make them comfortable.